EPA+DPA+DHA (OmegaCheck): Normal Range & What a Low Omega-3 Result Means

If your EPA+DPA+DHA result came back low, it means your body doesn't have as much omega-3 available as is considered ideal for long-term cardiovascular health. That's the headline. The rest of this page is about why that happens, what it does and doesn't predict, and how to move it — because this is one of the few blood tests where the number is genuinely in your hands.

The test itself measures the three main long-chain omega-3 fatty acids — eicosapentaenoic acid (EPA), docosapentaenoic acid (DPA), and docosahexaenoic acid (DHA) — added together and reported as a single percentage of your total fatty acids. Many labs report this bundle under the brand name OmegaCheck.

The one idea that explains this whole page: this test tells you what made it into your blood — not what you ate. Anyone can say "I eat salmon twice a week." Only the blood level answers the question that actually matters: did enough omega-3 actually arrive?

Clinical takeaway. Higher is generally better; low is the actionable finding. Low omega-3 status is associated with greater cardiovascular and sudden-cardiac-death risk — an association, not a diagnosis — and it usually responds to diet and supplements within weeks to months.

At a glance

• What it measures: how much omega-3 (EPA + DPA + DHA combined) actually reached your bloodstream, as a percentage by weight.
• Why it's ordered: because intake and blood level aren't the same thing — this checks whether your diet or supplements are actually landing.
• The direction that matters: low. High is generally favorable; a "high" flag is rarely a problem.
• What moves it: oily fish, fish-oil or algal-oil supplements — reflected in your blood over roughly 4–8 weeks.
• What it can't tell you: whether you'll have a cardiac event, the health of your arteries, or your tissue (red-cell) omega-3 stores — that's a related but different test, the Omega-3 Index.
• Best used: tracked over time, re-tested after a dietary or supplement change.

Food on your plate is not the same as omega-3 in your blood

This is the single most useful idea on this page, and it's the reason the test exists at all. What you eat is only the first step in a chain, and things go missing at every link:

Your diet is an input. This test is the output. When someone eats fish regularly and still tests low, nothing paradoxical has happened — the chain simply leaked somewhere. That's information you can act on, and it's information no food diary can give you.

Two people, the same fish intake

Person A eats salmon twice a week. Their EPA+DPA+DHA is 2.9% — the high-risk tier.

Person B eats salmon twice a week. Their EPA+DPA+DHA is 6.7% — comfortably optimal.

Same reported diet, opposite results. The gap comes down to portion size, how consistent "twice a week" really is over months, whether a supplement is in play and what's actually in it, absorption, and ordinary individual variation. Person A doesn't need to be told to eat more fish in the abstract — they need to know their current approach isn't landing, which is exactly what the test just told them.

Your result, and what it does not mean

What counts as low, moderate, or optimal? (OmegaCheck risk tiers)

OmegaCheck reports EPA+DPA+DHA as a percentage by weight and sorts it into relative-risk tiers, drawn from the top and bottom quartiles of a reference population:

Read it against your own report. Cutoffs and units are assay-specific, and different labs may present this slightly differently. "Relative risk" here is a population statistic — it describes groups, not your individual fate. Use your own lab's stated range as the reference, and treat the tier as a target to move toward, not a verdict.

What is DPA — and why is it bundled with EPA and DHA?

Most people recognize EPA and DHA but have never heard of DPA (docosapentaenoic acid). It's the "middle" omega-3: your body can convert EPA into DPA and DPA into DHA, so DPA sits between the two better-known fatty acids as an intermediate. It's less studied on its own, but it's biologically active and shows up in the same foods (oily fish), which is why OmegaCheck sums all three into one number rather than reporting DPA separately. In short: DPA is a genuine long-chain omega-3, and including it gives a slightly fuller picture of your omega-3 status than EPA + DHA alone.

EPA+DPA+DHA (OmegaCheck) vs. the Omega-3 Index — what's the difference?

These two tests sound alike and get mixed up constantly, but they measure different things:

Both are legitimate ways to gauge omega-3 status; they simply sample different compartments over different timeframes. If you're comparing results from two labs and the numbers don't match, this is often why — you may be looking at two different tests. See Omega-3 Index (confirm slug before linking) for that measure.

What actually raises a low result

• Oily fish — salmon, sardines, mackerel, herring, and anchovies are the richest sources. Two to three servings a week is a common target.
• Fish-oil or algal-oil supplements — a practical route, especially if you don't eat fish. Algal (algae-derived) omega-3 is a vegan option supplying DHA directly (it's where the fish get it) and a reasonable choice for plant-based diets.
• Plant sources (flax, chia, walnuts) supply ALA, a shorter omega-3 the body converts to EPA/DHA only inefficiently — helpful, but rarely enough on their own to move a low result much.

Two clinical caveats, stated plainly. (1) Omega-3's clearest, best-established effect is lowering triglycerides — roughly 7–10% at about 1 g/day of EPA+DHA. (2) Whether omega-3 supplements reduce cardiovascular events is genuinely mixed across large trials, even though low omega-3 status tracks with higher risk. Diet-first is the mainstream recommendation; discuss higher supplement doses with your clinician, particularly if you're on blood thinners.

Why is my EPA+DPA+DHA low even though I take fish oil?

This is one of the most common — and most confusing — versions of this result. It isn't a contradiction; it's the "intake isn't blood level" principle showing up in real life. The usual explanations:

• The dose is too low. Many supplements deliver far less EPA+DHA per capsule than the label's headline "fish oil 1000 mg" suggests — that figure is the oil, not the omega-3 in it. Check the EPA and DHA amounts specifically.
• It's taken inconsistently. A few capsules a week won't build a blood level the way daily use does.
• You re-tested too soon. It takes roughly 4–8 weeks of consistent intake for the change to show up. Testing two weeks in mostly measures where you started.
• The product is weak or oxidized. Quality varies; oil that has gone rancid delivers less than it claims, and old or badly stored capsules are common culprits.
• It's taken without food. These are fats — absorption is generally better with a meal, especially one containing some fat.
• Individual variation. Absorption, metabolism, and baseline diet genuinely differ between people; some simply need more to reach the same level.

The practical move is to check the actual EPA+DHA milligrams you're getting daily, take it consistently with food for a couple of months, and re-test. If the number still hasn't moved, that's a worthwhile conversation to have with your clinician.

The pattern that matters: OmegaCheck read with your triglycerides

One number rarely tells a story; two often do. Triglycerides are the lipid omega-3 most directly affects, so reading these two together is how clinicians actually reason about this result — and it separates "you need more omega-3" from "something else is going on":

None of these is a diagnosis — they're starting points for a conversation, read alongside the rest of your lipid panel and your overall cardiovascular picture. But the logic is worth carrying: a low omega-3 level means something different in someone with normal triglycerides than in someone whose metabolic markers are also drifting.

Can you actually change this result?

Part of why this test is worth paying attention to is that many cardiovascular markers are largely fixed, and this one isn't:

That contrast is the point. When a marker you can't move comes back unfavorable, the information is mostly about risk awareness. When this one comes back low, it's an instruction — and one of the few in a lipid workup where the follow-up is genuinely in your control.

The case for tracking it over time

This is one of the few lab values you can deliberately change, which makes a single reading less useful than a trend. But it only moves in response to sustained intake, not recent meals — which is what makes the timing of a re-test matter:

So: get a low result, change something real, and re-test in about 8–12 weeks. Watching the number climb from the high-risk tier toward optimal tells you whether your approach is working — which is something no single snapshot, and no amount of eating fish and hoping, can answer.

Questions this result answers — and questions it doesn't

This test helps answer:

• Am I getting enough omega-3?
• Is my supplement or diet actually working?
• Has my level moved since I changed something?
• Where do I sit relative to the lower-risk range?

This test cannot answer:

• Do I have heart disease? — it doesn't image plaque or measure heart function.
• Will I have a heart attack? — it's a population risk-marker, not a prediction for you.
• Which fatty acid is low? — the bundled number doesn't break out EPA vs DPA vs DHA.
• What are my long-term tissue stores? — that's the Omega-3 Index (red-cell), a related but separate test.
• Do I absorb fats normally? — a low result is consistent with poor absorption but doesn't demonstrate it.

Common misconceptions

• Eating fish does not guarantee a good level. Intake is the input; this test is the output — and the two often disagree.
• A low result is not a diagnosis. It's a modifiable risk-marker tied to recent omega-3 intake, not evidence of heart disease.
• A low result despite taking fish oil is not a contradiction. It usually means the dose, consistency, product, or timing didn't add up to enough.
• "High" is not bad. For this marker, higher is generally the goal; a high flag usually reflects good fish or supplement intake.
• More is not unlimited-better. Very high supplement doses (>~3 g/day EPA+DHA) can lengthen bleeding time — relevant if you're on blood thinners or facing surgery.
• OmegaCheck is not the Omega-3 Index. Different fatty acids, different blood compartment — don't compare them one-to-one.
• Plant omega-3s (ALA) are not a fast fix. The body converts them to EPA/DHA inefficiently; they rarely move a low OmegaCheck result much on their own.

Clinical pearls

• The test measures what arrived, not what was eaten — dietary history and blood level routinely diverge, which is precisely why the marker is ordered.
• EPA+DPA+DHA is a status marker, not a diagnosis — it reflects intake and tracks risk at the population level.
• The actionable direction is low; a high result is generally favorable.
• Its most robust physiological effect is triglyceride lowering; the CV-event evidence for supplementation is mixed and shouldn't be overstated.
• It's modifiable and worth re-testing after a diet or supplement change — the trend beats the snapshot.
• Distinguish it from the Omega-3 Index (RBC, EPA+DHA only) to avoid comparing unlike tests.

Read together with

• Omega-3 Index (confirm slug) — the red-cell, longer-term companion measure.
• Triglycerides — the lipid most directly moved by omega-3 intake.
• Omega-6 : Omega-3 ratio / AA:EPA ratio (confirm slugs) — context for balance between fatty-acid families.
• Your lipid panel and overall cardiovascular risk — which frame what a low omega-3 result means for you.

In one sentence

EPA+DPA+DHA (OmegaCheck) tells you how much omega-3 actually reached your blood rather than how much you meant to eat — and a low result, while associated with higher cardiovascular risk, is one of the few lab findings you can deliberately fix and then re-test.

The bottom line

This test answers a question your diet can't: did enough omega-3 actually make it in? Higher is generally better; a low result is the one to act on, since low omega-3 status is linked to greater cardiovascular and sudden-cardiac-death risk. It's a risk-marker, not a diagnosis. And if you're already eating fish or taking a supplement and still tested low, that's not a failure — it's the test doing its job, telling you the current approach isn't landing. Adjust, give it a couple of months, and re-test to see the number move.